|
Mutation Information
|
Mutation Site
|
M204V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.M204V+rt.L180M;rt.M204V+rt.L180M+rt.L80V;rt.M204V+rt.L180M+rt.V173L;rt.M250L+rt.M204V+rt.L180M;rt.M250V+rt.M204V+rt.L180M;rt.M204V+rt.A194T+rt.A181G+rt.L180M |
|
Relevant Drug
|
lamivudine (LAM);telbivudine (LDT);entecavir (ETV);adefovir dipivoxil (ADV) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
27694733
|
|
Disease
|
Chronic hepatitis B
|
|
Published Year
|
2016 |
|
Journal
|
Journal of infection in developing countries |
|
Title
|
Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China. |
|
Author
|
Qian F,Qin J,Li D,Ma Z,Zhang H,Jin F,Wang W |
|
Evidence
|
Among patients who harbored rtM204 combination mutations, rtM204I and rtM204V were significantly associated with rtL80I/V and rtL180M, respectively.
|
|
|
HBV Mutation Detail Information